ライフサイエンスコーパス: nuclear factor-kappa B

1 ak1 (p21-activated kinase -1) --> NF-kappaB (nuclear factor-kappa B).

2 -1, tribbles 3, reactive oxygen species, and nuclear factor kappa B)?

3 phosphorylation and nuclear translocation of nuclear factor kappa B.

4 opolysaccharide (LPS) -induced activation of Nuclear Factor kappa B.

5 togen-activated protein kinase and activates nuclear factor kappa B.

6 n of both interferon regulatory factor 3 and nuclear factor kappa B.

7 bition of glycogen synthase kinase-3beta and nuclear factor kappa B.

8 bition of glycogen synthase kinase-3beta and nuclear factor kappa B.

9 s both C and T alleles were found to bind to nuclear factor kappa B.

10 D91 triggers signalling cascades to activate nuclear factor-kappa B.

11 rivative of dithiocarnamate, an inhibitor of nuclear factor- kappa B.

12 hanism for induction of CDX2 is dependent on nuclear factor kappa B, a crucial transcription factor i

13 Inflammatory super enhancers formed by nuclear factor-kappa B accumulate at the expense of imme

14 bic acid and dehydroascorbic acid attenuated nuclear factor kappa B activation and normalized coagula

15 lar signal-regulated kinase 1 and 2-mediated nuclear factor kappa B activation in mice.

16 e course plots of Lipopolysaccharide-induced Nuclear Factor kappa B activation in mouse embryo fibrob

17 ardiac mitochondrial respiratory efficiency, nuclear factor kappa B activation, and caspase activitie

18 y include molecular interactions upstream of Nuclear Factor kappa B activation.

19 nhibited tumor necrosis factor-alpha induced nuclear factor-kappa B activation by 27.5% at 2 mg/ml, w

20 cyclophosphamide with mecamylamine suggested nuclear factor-kappa B activation in the chronic inflamm

21 tinamide effectively attenuated postischemic nuclear factor-kappa]B activation and exhibited robust a

22 ects that were accompanied by a reduction in nuclear factor kappa B activity and cell surface levels

23 LPS-induced nuclear factor kappa B, Akt, and p38 activation is enhan

24 m was associated with increased inhibitor of nuclear factor-kappa B alpha (IkappaBalpha) expression,

25 location of transcription factors, including nuclear factor kappa B, although its role in PCa was lar

26 ecule 1-dependent and leads to activation of nuclear factor kappa B and extracellular signal-regulate

27 nate attenuated the HS-induced activation of nuclear factor kappa B and reduced the expression of pro

28 nate attenuated the HS-induced activation of nuclear factor kappa B and reduced the expression of pro

29 Immunofluorescence showed colocalization of nuclear factor kappa-B and OCN in diseased and normal va

30 reby enabling constitutive activation of the nuclear factor-kappa B, and contributing to chronic infl

31 ity of activated glucocorticoid receptor and nuclear factor kappa-b appeared to join pre-existing P30

32 Our data demonstrate that miR-146a controls nuclear factor kappa B-dependent inflammatory responses

33 ing LTR-driven HIV-1 gene transcription in a nuclear factor kappa B-dependent manner.

34 (Hz), signals NOS induction through ERK- and nuclear factor kappa B-dependent pathways and has been d

35 human peripheral blood mononuclear cells and nuclear factor kappa B-dependent transcription in human

36 sponse genes, pointing to the suppression of nuclear factor kappa B-dependent transcription.

37 Cellular activation was assessed by nuclear factor-kappa B-driven luciferase activity, cytok

38 t HEK293 cells, HEK293-TLR2 cells had marked nuclear factor-kappa B-driven luciferase activity, had m

39 in inflammatory and cancer pathways, such as nuclear factor kappa B, EGF, Wnt, and B-cell lymphoma 2.

40 NF-kappaB (nuclear factor kappa B) family transcription factors are

41 six cytokines that regulate the activity of nuclear factor kappa B in 293T cells.

42 chanism of action is partly mediated through nuclear factor-kappa B inhibition, resulting in apoptosi

43 nhibitor PD98059, the Src inhibitor pp2, the nuclear factor- kappa B inhibitor caffeic acid phenethyl

44 In vivo administration of a nuclear factor-kappa B inhibitory peptide, NBD, blocked

45 ylated and thereby inhibited by inhibitor of nuclear factor kappa B kinase subunit beta (IKKbeta) to

46 howed that Hsp90 interacts with inhibitor of nuclear factor kappa-B kinase (IKK) together with cochap

47 Pharmacological inhibition of inhibitor of nuclear factor kappa-B kinase subunit beta (IKKbeta), bu

48 Nuclear Factor Kappa B levels were increased in BAT, whe

49 ncreased expression of receptor activator of nuclear factor kappa B ligand (RANK-L) due to pro-inflam

50 on and inactivation of Receptor Activator of Nuclear factor Kappa B Ligand (RANKL) and osteoprotegeri

51 Receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegeri

52 clast (OC) response to receptor activator of nuclear factor kappa B ligand (RANKL) and thus bone meta

53 ng factor (M-CSF), and receptor activator of nuclear factor kappa B ligand (RANKL) expression, but th

54 osis factor (TNF), and receptor-activator of nuclear factor kappa B ligand (RANKL) were significantly

55 nonoclonal antibody to receptor activator of nuclear factor kappa B ligand, has completed its major f

56 nsing receptor and the receptor activator of nuclear factor kappa B ligand/receptor activator of nucl

57 that stimulation with receptor activator of nuclear factor kappa-B ligand (RANKL) resulted in a robu

58 oxidase (MPO), and the cytokine receptor for nuclear factor kappa-B ligand (RANKL) were significantly

59 ze salivary levels of receptor activator for nuclear factor kappa-B ligand (RANKL), osteoprotegerin,

60 ted T cells to produce receptor activator of nuclear factor kappa-B ligand (RANKL), which, in turn, p

61 TNF-alpha), as well as receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast

62 tal tissue and induces receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK-osteoproteger

63 human monoclonal anti-receptor activator of nuclear factor kappa-B ligand antibody, with zoledronic

64 Change in circulating receptor activator of nuclear factor kappa-B ligand was higher in the interven

65 chemotactic protein 1, receptor activator of nuclear factor kappa-B ligand, and macrophage colony-sti

66 lcin, osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, vascular endothelial grow

67 factor (TNF)-alpha and receptor activator of nuclear factor kappa-B ligand; these cytokines were also

68 issue homogenates, and receptor activator of nuclear factor-kappa B ligand (RANKL) activation was ana

69 s and osteoclasts, and receptor activator of nuclear factor-kappa B ligand (RANKL) activity.

70 , expression of activated receptor activator nuclear factor-kappa B ligand (RANKL) and bone density i

71 The receptor activator of nuclear factor-kappa B ligand (RANKL) inhibitor osteopro

72 ) PBMCs was induced by receptor activator of nuclear factor-kappa B ligand (RANKL), either alone or i

73 histochemistry for the receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin (

74 ranscription factor-2, receptor activator of nuclear factor-kappa B ligand (RANKL), sclerostin, and D

75 LR-4, osteoprotegerin, receptor activator of nuclear factor-kappa B ligand (RANKL), tumor necrosis fa

76 osorbent assay for: 1) receptor activator of nuclear factor-kappa B ligand (RANKL); 2) osteoprotegeri

77 (IL)-6, IL-8, soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), osteoprotegerin

78 mmunoreactivity to the receptor activator of nuclear factor-kappa B ligand at day 7 post-treatment, s

79 nuclear factor-kappa B-receptor activator of nuclear factor-kappa B ligand interaction for osteoclast

80 interleukin-1beta and receptor activator of nuclear factor-kappa B ligand than group EP-HN019 (P <0.

81 tegerin and decreasing receptor activator of nuclear factor-kappa B ligand.

82 lectrophoresis; RANKL, receptor activator of nuclear factor kappa B-ligand; NFATc1, nuclear factor of

83 eracting protein 2) to coordinate NF-kappaB (nuclear factor kappa B)-mediated cytokine responses.

84 ulting in de novo lipogenesis, and increased nuclear factor kappa B-mediated inflammation act in conc

85 enomena at the organismal level, we assessed nuclear factor kappa B (NF-kappaB) activation (indicativ

86 ction in cultured hepatoma cells, leading to nuclear factor kappa B (NF-kappaB) activation and the pr

87 Because cIAP-1 and cIAP-2 also promote nuclear factor kappa B (NF-kappaB) activation by the can

88 intestinal epithelial cells and also induced nuclear factor kappa B (NF-kappaB) activation in HEK293T

89 T-cell proliferation, T-cell subsests, nuclear factor kappa B (NF-kappaB) activation, and Bax a

90 at least three different pathways leading to nuclear factor kappa B (NF-kappaB) activation, apoptosis

91 atterns of c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappaB) activation.

92 One potential mechanism is to suppress nuclear factor kappa B (NF-kappaB) activation.

93 f the most prevalent being the disruption of nuclear factor kappa B (NF-kappaB) activation.

94 cells, especially those cells dependent upon nuclear factor kappa B (NF-kappaB) activation.

95 the expression of genes reflecting enhanced nuclear factor kappa B (NF-kappaB) activity were noted i

96 r 4), interferon regulatory factor-3 (IRF3), nuclear factor kappa B (NF-kappaB) activity, and proinfl

97 ecific lipin-1 deficiency diminished hepatic nuclear factor kappa B (NF-kappaB) activity, limited liv

98 RF triggered a high but nonsustained peak of nuclear factor kappa B (NF-kappaB) activity.

99 uclear export sequence (NES) of inhibitor of nuclear factor kappa B (NF-kappaB) alpha (IkappaBalpha)

100 (TRAF1-6) links the TNFR superfamily to the nuclear factor kappa B (NF-kappaB) and activator protein

101 vestigated the role of transcription factors nuclear factor kappa B (NF-kappaB) and signal transducer

102 The Rel-like transcription factors nuclear factor kappa B (NF-kappaB) and the calcineurin-d

103 The transcription factor nuclear factor kappa B (NF-kappaB) and the long non-codi

104 Nuclear factor kappa B (NF-kappaB) and type 1 interferon

105 -protein interaction (PPI) interface between nuclear factor kappa B (NF-kappaB) essential modulator (

106 TNF-alpha and phospho-nuclear factor kappa B (NF-kappaB) expression in ocular

107 TRF also showed a greater inhibition on the nuclear factor kappa B (NF-kappaB) expression than T and

108 alling pathways leading to activation of the nuclear factor kappa B (NF-kappaB) family of transcripti

109 e expression by transcription factors of the nuclear factor kappa B (NF-kappaB) family.

110 The transcription factor nuclear factor kappa B (NF-kappaB) has been implicated i

111 Constitutive activation of nuclear factor kappa B (NF-kappaB) has been linked with

112 tivated the immunologic transcription factor nuclear factor kappa B (NF-kappaB) in DPSCs.

113 a 12,14- Prostaglandin J2 (15dPGJ2) inhibits Nuclear factor kappa B (NF-kappaB) in human myocytes and

114 The role of nuclear factor kappa B (NF-kappaB) in oxidative stress,

115 The role of nuclear factor kappa B (NF-kappaB) in the glucose-mediat

116 The involvement of nuclear factor kappa B (NF-kappaB) in TNF-induced increa

117 e report that systemic administration of the nuclear factor kappa B (NF-kappaB) inhibitor Bay 11-7085

118 A20, a potent antiinflammatory and nuclear factor kappa B (NF-kappaB) inhibitory protein, h

119 The nuclear factor kappa B (NF-kappaB) intracellular signall

120 Nuclear factor kappa B (NF-kappaB) is a key mediator of

121 Nuclear Factor kappa B (NF-kappaB) is a transcription fa

122 The transcription factor nuclear factor kappa B (NF-kappaB) is activated in human

123 Nuclear factor kappa B (NF-kappaB) is also activated and

124 Nuclear factor kappa B (NF-kappaB) is an inducible trans

125 The nuclear factor kappa B (NF-kappaB) is believed to play a

126 The transcription factor nuclear factor kappa B (NF-kappaB) is constitutively act

127 We utilized a transgenic mouse model where nuclear factor kappa B (NF-kappaB) is selectively inhibi

128 The alternative or noncanonical nuclear factor kappa B (NF-kappaB) pathway regulates the

129 (IL)12 or IL18 as well as inhibition of the nuclear factor kappa B (NF-kappaB) pathway reversed NK c

130 rse cellular and biological functions of the nuclear factor kappa B (NF-kappaB) pathway, together wit

131 The nuclear factor kappa B (NF-kappaB) pathways in Drosophil

132 ) 3' untranslated region (UTR) and activates nuclear factor kappa B (NF-kappaB) pathways that contrib

133 cycle progression and I-kappa B kinase (IKK)/nuclear factor kappa B (NF-kappaB) signaling contributes

134 We investigated the role of nuclear factor kappa B (NF-kappaB) signaling in HGF/SF-m

135 MRV miRNAs, we screened for their effects on nuclear factor kappa B (NF-kappaB) signaling in the pres

136 biquitinated chains from key proteins in the nuclear factor kappa B (NF-kappaB) signaling pathway.

137 Nuclear factor kappa B (NF-kappaB) signaling plays criti

138 te/macrophage function through inhibition of nuclear factor kappa B (NF-kappaB) signaling.

139 Here we demonstrate that the dynamics of Nuclear Factor kappa B (NF-kappaB) signalling and the ce

140 or endoplasmic reticulum stress and initiate nuclear factor kappa B (NF-kappaB) signalling.

141 The p52/p100 nuclear factor kappa B (NF-kappaB) subunit (NF-kappaB2)

142 DNA binding activity of nuclear factor kappa B (NF-kappaB) that transactivates m

143 CD47 expression was found to be regulated by nuclear factor kappa B (NF-kappaB) through a specific re

144 Nuclear factor kappa B (NF-kappaB) transcription factors

145 phate (NAD(P)H)-oxidase and translocation of nuclear factor kappa B (NF-kappaB) were also evaluated.

146 Recently, VHL loss was shown to activate nuclear factor kappa B (NF-kappaB), a family of transcri

147 Antagonists of nuclear factor kappa B (NF-kappaB), cyclooxygenase pathw

148 acts as an upstream activator of astroglial nuclear factor kappa B (NF-kappaB), leading to the relea

149 is is strongly associated with inhibition of nuclear factor kappa B (NF-kappaB), proapoptotic activat

150 ase for p27(Kip1), through activation of p52 nuclear factor kappa B (NF-kappaB)-2.

151 rophages enhance myofibroblast survival in a nuclear factor kappa B (NF-kappaB)-dependent manner and

152 impaired by more than 95%, but no defect in nuclear factor kappa B (NF-kappaB)-induced gene expressi

153 Here we identified hepatic nuclear factor kappa B (NF-kappaB)-inducing kinase (NIK)

154 Nuclear factor kappa B (NF-kappaB)-mediated transcriptio

155 cellular DNA microarrays, we found that many nuclear factor kappa B (NF-kappaB)-responsive genes were

156 and identified binding sites for GATA-6 and nuclear factor kappa B (NF-kappaB).

157 location and transcriptional activity of the nuclear factor kappa B (NF-kappaB).

158 6 (SETD6) monomethylates the RelA subunit of nuclear factor kappa B (NF-kappaB).

159 g effects on translocation and activation of nuclear factor kappa B (NF-kappaB).

160 ed in monocytes and is capable of activating nuclear factor kappa B (NF-kappaB).

161 on of multiple signaling pathways, including nuclear factor kappa B (NF-kappaB).

162 p65, the transcriptionally active subunit of nuclear factor kappa B (NF-kappaB).

163 quired for API2-MALT1 to stimulate canonical nuclear factor kappa B (NF-kappaB).

164 ated the hepatocellular damage by inhibiting nuclear factor kappa B (NF-kappaB)/cyclooxygenase 2 sign

165 factor activity [myocyte enhancer factor-2, nuclear factor kappa B (NF-kappaB)].

166 decrease in PKC activity, and inhibition of nuclear factor kappa B (NF-kB) translocation, were attri

167 CARD14 activates nuclear factor kappa B (NF-kB), and compared with wild-t

168 cluding TNF-alpha and IL-6 and activation of nuclear factor kappa B (NF-kB/p65), p38 mitogen-activate

169 Nuclear factor kappa-B (NF-kappaB) activation and produc

170 gulators linked to TNF-alpha/TNFR signaling, nuclear factor kappa-B (NF-kappaB) activation, autophagy

171 ll receptor (BCR) signaling and constitutive nuclear factor kappa-B (NF-kappaB) activation, which is

172 response element-binding protein (CREB) and nuclear factor kappa-B (NF-kappaB) are two ubiquitous tr

173 of this study is to investigate the role of nuclear factor kappa-B (NF-kappaB) in regulating IL-6 ex

174 NOS1 is complex but recent data suggest that nuclear factor kappa-B (NF-kappaB) is an important trans

175 recent Immunity articles probe the roles of Nuclear Factor kappa-B (NF-kappaB) pathways in survival

176 egulated kinase (ERK), calcium (Ca(2+)), and nuclear factor kappa-B (NF-kappaB) pathways, response dy

177 Here, we identify a role for the Nuclear Factor kappa-B (NF-kappaB) signaling pathway in

178 Nuclear factor kappa-B (NF-kappaB), a key downstream pla

179 A key antiapoptotic transcription factor, nuclear factor kappa-B (NF-kappaB), is known to be criti

180 Nuclear factor kappa-B (NF-kappaB)-regulated inflammator

181 (residues 67-206), the primary inhibitor of nuclear factor kappa-B (NF-kappaB).

182 herapy resistance involves the activation of nuclear factor kappa-B (NF-kappaB).

183 gical inhibitors of either IL-8 secretion or nuclear factor- kappa B (NF-kappa B) activation on IL-8

184 d the binding of the p65 (RelA) component of nuclear factor-kappa B (NF-kappa B) to the endogenous E-

185 a (IkappaBalpha) expression, which inhibited nuclear factor-kappa B (NF-kappaB) activation and induct

186 ad of colonic tumors and increased STAT3 and nuclear factor-kappa B (NF-kappaB) activation in colon.

187 Pharmacokinetics (PKs), nuclear factor-kappa B (NF-kappaB) activation, and intra

188 d mitogen-activated protein (MAP) kinase and nuclear factor-kappa B (NF-kappaB) activation, and the s

189 Notch-1 can increase nuclear factor-kappa B (NF-kappaB) activity through a va

190 The nitric oxide concentration and nuclear factor-kappa B (NF-kappaB) activity were measure

191 carcinoma cells (T24 cells), and TPA-induced nuclear factor-kappa B (NF-kappaB) activity with human h

192 idermis of mice lacking transcription factor nuclear factor-kappa B (NF-kappaB) activity, primary hai

193 the activation of the transcription factors nuclear factor-kappa B (NF-kappaB) and activator protein

194 ed PHB expression on TNF-alpha activation of nuclear factor-kappa B (NF-kappaB) and epithelial barrie

195 ithelia in Hashimoto's thyroiditis activates nuclear factor-kappa B (NF-kappaB) and induces pro-infla

196 GF), inducible nitric oxide synthase (iNOS), nuclear factor-kappa B (NF-kappaB) and intercellular adh

197 The transcription factor nuclear factor-kappa B (NF-kappaB) and mitogen-activated

198 ctivates typical cytokine signal pathways of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activ

199 The decline in the activation of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activ

200 genotoxic and oncogenic stress activates the nuclear factor-kappa B (NF-kappaB) and p53 proteins; how

201 amic interplay of two transcription factors, nuclear factor-kappa B (NF-kappaB) and peroxisome prolif

202 UPR, there was transcriptional regulation by nuclear factor-kappa B (NF-kappaB) and RNA stabilization

203 t-7b cluster and identified several putative nuclear factor-kappa B (NF-kappaB) consensus elements.

204 P-ribose polymerase, alteration in c-myc and nuclear factor-kappa B (NF-kappaB) expression, regulatio

205 The nuclear factor-kappa B (NF-kappaB) family of transcripti

206 tion of proinflammatory transcription factor nuclear factor-kappa B (NF-kappaB) in 7-week-old mdx mic

207 imately 40,000 genes, and tested the role of nuclear factor-kappa B (NF-kappaB) in maintaining an act

208 ic proteins and the proinflammatory molecule nuclear factor-kappa B (NF-kappaB) in the retina of Lewi

209 Nuclear factor-kappa B (NF-kappaB) is a key transcriptio

210 we have shown that the transcription factor nuclear factor-kappa B (NF-kappaB) is activated by BCR-A

211 Nuclear factor-kappa B (NF-kappaB) is classically known

212 One of the primary physiological roles of nuclear factor-kappa B (NF-kappaB) is in the immune syst

213 affects expression of receptor activator of nuclear factor-kappa B (NF-kappaB) ligand (RANKL), a pot

214 Constitutive activation of the nuclear factor-kappa B (NF-kappaB) pathway is a hallmark

215 constitutive activation of the antiapoptotic nuclear factor-kappa B (NF-kappaB) pathway, which can in

216 ne of these main signaling mechanisms is the nuclear factor-kappa B (NF-kappaB) pathway, which integr

217 f myeloid cells, are partly regulated by the nuclear factor-kappa B (NF-kappaB) pathway.

218 PGE(2) and the transcription factor nuclear factor-kappa B (NF-kappaB) regulate IL-1beta-sti

219 d activators of transcription 1 (STAT1), and nuclear factor-kappa B (NF-kappaB) signaling in Lilrb3(-

220 dy, we show that the activation of classical nuclear factor-kappa B (NF-kappaB) signaling increases t

221 nvading pathogens, their ability to regulate nuclear factor-kappa B (NF-kappaB) signaling, interleuki

222 The transcription factor nuclear factor-kappa B (NF-kappaB) subunit p65 is phosph

223 IL-6 expression is regulated by the nuclear factor-kappa B (NF-kappaB) transcription factor,

224 Nuclear factor-kappa B (NF-kappaB), a master regulator o

225 kine is dependent upon transcription factors nuclear factor-kappa B (NF-kappaB), stimulating protein-

226 eading to activation of transcription factor nuclear factor-kappa B (NF-kappaB), which is a central r

227 like receptor 4 (TLR4)-dependent pathway via nuclear factor-kappa B (NF-kappaB), while simultaneously

228 so stimulated IFN-beta promoter activity and nuclear factor-kappa B (NF-kappaB)-dependent transcripti

229 einase (MMP)-1, as well as the activation of nuclear factor-kappa B (NF-kappaB).

230 tes exhibited spontaneous hyperactivation of nuclear factor-kappa B (NF-kappaB).

231 le for the inflammatory transcription factor nuclear factor-kappa B (NF-kappaB).

232 1 to establish baseline pharmacodynamics for nuclear factor-kappa B (NF-kB).

233 and activator of transcription 3 (STAT3) and nuclear factor-kappa B (NF-kB).

234 cell cycle and prosurvival pathways (such as nuclear factor kappa B [NF-kappaB], AKT), pathways regul

235 monstrated a signaling pathway from HIF-1 to nuclear factor kappa B (NFkappaB) activation to enhanced

236 Furthermore, when TGFbeta1-induced nuclear factor kappa B (NFkappaB) activation was inhibit

237 f intrapancreatic trypsinogen activation and nuclear factor kappa B (NFkappaB) activation, the two ma

238 Early intra-acinar nuclear factor kappa B (NFkappaB) activation, which occu

239 activation, ITCH inhibits NOD2:RIP2-induced nuclear factor kappa B (NFkappaB) activation.

240 in terms of interleukin (IL)-8 promoter and nuclear factor kappa B (NFkappaB) activity, were observe

241 IkappaBalpha enhances the rate of release of nuclear factor kappa B (NFkappaB) from DNA target sites

242 Nuclear factor kappa B (NFkappaB) plays a potential role

243 tion by laminar shear stress is dependent on nuclear factor kappa B (NFkappaB) subunits p50 and p65 b

244 a) is a potent cytokine that signals through nuclear factor kappa B (NFkappaB) to activate a subset o

245 or (TRPV1) and Ca(2+) to microglial IL-6 and nuclear factor kappa B (NFkappaB) translocation with ele

246 The transcription factor, nuclear factor kappa B (NFkappaB), is rapidly activated

247 nt protein deacetylase sirtuin-6 (SIRT6) and nuclear factor kappa B (NFkappaB), sequesters GR express

248 infection of hepatic cells by HCV stimulates nuclear factor kappa B (NFkappaB)-dependent production o

249 n (EMT), but also constitutive activation of nuclear factor kappa B (NFkappaB; RELA).

250 Moreover, LPS induced nuclear factor kappa-B (NFkappaB) activation was enhance

251 d to dramatically reduce the level of active nuclear factor kappa-B (NFkappaB) in the cell; NFkappaB

252 ivator of transcription factor 6 (STAT6) and nuclear factor-kappa B (NFkappaB) in mice and cells.

253 onally activated by mTOR complex 2 (mTORC2): nuclear factor-kappa B (NFkappaB) signaling cascade.

254 essing fibroblasts induced the activation of nuclear factor-kappa B (NFkappaB), a regulator fibronect

255 This includes the Nuclear-factor-kappa-B (NFkappaB) pathway, which is cent

256 Nuclear factor kappa B (NFkB) pathway activation represe

257 Streptococcus pneumoniae co-opts the nuclear factor kappa B (NFkB)-regulated proteins polymer

258 ese genes were involved in interferon alpha, nuclear factor-kappa B (NFkB), extracellular signal-rela

259 onase exerts an effect via downregulation of nuclear factor kappa B (NFKbeta) by specific microRNAs (

260 cally regulated by p38delta isoform, whereas nuclear factor kappa B (NFsmall ka, CyrillicB) pathway r

261 the transcriptional level without affecting nuclear factor kappa B nuclear binding.

262 factors, such as glucocorticoid receptor and nuclear factor kappa-b, on the three-dimensional organiz

263 Cs), a phenomenon not mediated by changes to nuclear factor-kappa B or hydrogen sulfide but that occu

264 in the presence of antagonists of NFkappaB (nuclear factor kappa B) or iNOS activity, NO synthesis a

265 factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system involved i

266 ich also correlated with increased levels of nuclear factor kappa B p52 and decreased levels of c-Jun

267 Blocking phosphorylation of nuclear factor kappa B p65 on Ser536 inhibited the emerg

268 iated genes and drove hyperactivation of the nuclear factor kappa B p65 pathway.

269 a4beta1, which resulted in signaling through nuclear factor kappa B p65, protein kinase B1, and p38 m

270 vo that depends on Ser536 phosphorylation of nuclear factor kappa B p65; this pathway may hold valuab

271 -0.59 (-0.8, -0.3) mmol/L; P < 0.001], total nuclear factor kappa-B p65 [-0.016 (-0.022, -0.011) comp

272 t induces expression of ZEB1 by a NF-kappaB (nuclear factor kappa B) p65-dependent mechanism.

273 e pathway that, together with the Rho-kinase nuclear factor kappa B pathway (NF-kB), are required for

274 om platelets, particularly those part of the nuclear factor kappa B pathway, are associated with BMI,

275 tors were found to inactivate members of the nuclear factor kappa B pathway.

276 ied activating mutations in the noncanonical nuclear factor-kappa B pathway could give rise to ibruti

277 as 18q21 amplification or activation of the nuclear factor-kappa B pathway, as reported previously,

278 of the mitogen-activated protein kinase and nuclear factor kappa B pathways in MDSCs was MyD88 depen

279 rough regulating the activation of canonical nuclear factor kappa B, phosphatidylinositol-4,5-bisphos

280 phosphoinositide 3-kinase/phosphorylated Akt/nuclear factor kappa B (PI3K/pAkt/NFkappaB)-signaling pa

281 e immune system signaling pathways including nuclear factor-kappa B profoundly alter intestinal epith

282 Chronic alcohol consumption inhibited the nuclear factor kappa B proinflammatory cytokine pathway

283 ease (p<0.01) in the level of phosphorylated-nuclear factor kappa B protein.

284 es to determine the levels of phosphorylated nuclear factor kappa B protein.

285 id-state nanopore has been used to recognize Nuclear Factor-kappa B proteins (NF-kappaB), that are in

286 lonal antibody against receptor activator of nuclear factor kappa B (RANK) ligand, with zoledronic ac

287 omeostatic conditions, receptor activator of nuclear factor kappa-B (RANK) ligand on osteoblasts driv

288 uent bone loss via the receptor activator of nuclear factor-kappa B (RANK)-RANK ligand (RANKL)-osteop

289 eractions, such as the receptor activator of nuclear factor-kappa B-receptor activator of nuclear fac

290 d transcription factors, such as Bcl-2, Bax, nuclear factor kappa B, regulate the decision-making pow

291 s, cell cycle regulators, as well as p53 and nuclear factor-kappa B-responsive gene targets.

292 occurs through direct targeting of upstream nuclear factor kappa B signal transducers caspase recrui

293 es the proinflammatory transcription factors nuclear factor-kappa B, signal transducer and activators

294 and high-molecular weight isoforms activate nuclear factor-kappa B signaling pathways.

295 K/NFkappaB (mitogen-activated protein kinase/nuclear factor-kappa B) signals participate in regulatin

296 -responsive element (HRE)) and inflammation (nuclear factor kappa B) to obtain a chimeric promoter na

297 d activators of transcription and NF-kappaB (nuclear factor kappa B) transcription factors.

298 is known to coamplify with EGFR and regulate nuclear factor-kappa B transcriptional activity) had hig

299 diac tumor necrosis factor-alpha expression, nuclear factor kappa B translocation, obesity-induced pe

300 ession of TWEAK increased, the activation of nuclear factor-kappa B without affecting the activation